<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03508960</url>
  </required_header>
  <id_info>
    <org_study_id>CEOPDR</org_study_id>
    <nct_id>NCT03508960</nct_id>
  </id_info>
  <brief_title>Chinese EOPD Registry</brief_title>
  <official_title>The Chinese Early-onset Parkinson's Disease Registry</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Xiangya Hospital of Central South University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Xiangya Hospital of Central South University</source>
  <brief_summary>
    <textblock>
      The purpose of the Chinese Early-onst Parkinson's disease Registry (CEOPDR) is to develop a&#xD;
      database of persons with early-onset Parkinson's disease (EOPD) in China.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Parkinson's disease (PD) is the second most common disorder among degenerative neurological&#xD;
      disease. Early-onset PD (EOPD) has its unique clinical feature and genetic&#xD;
      basis.Investigators aim to establish a database of EOPD,and characterize the clinical&#xD;
      feature, genetic basis, environmental factors and their interactions EOPD in China.&#xD;
&#xD;
      Method:&#xD;
&#xD;
        1. Clinical feature will be measured by scales and neurological tests.Standard scales&#xD;
           includes: Unified Parkinson's Disease Rating Scale(UPDRS), Hoehn-Yahr stages, NMSS,&#xD;
           MMSE, PDSS(Parkinson disease sleep scales),Rapid Eye Movement Sleep Behaviour Disorder&#xD;
           Questionnaire(RBDQ-HK),ESS(Epworth Sleepiness Scale),Rome III functional constipation&#xD;
           scale，SCOPA-AUT (the Scale for Outcomes in PD for Autonomic Symptoms)，PFS(Parkinson&#xD;
           Fatigue Scale)，CH-RLSq，Hyposmia rating scale(HRS)HAMILT depression scale，the 39-item&#xD;
           Parkinson's Disease Questionnaire(PDQ-39)，Freezing of gait scale(FOG)，dyskinesia related&#xD;
           scales, Wearing-off scale(WO)&#xD;
&#xD;
        2. Peripheral blood from patients was collected for whole exome sequencing.&#xD;
&#xD;
        3. The environmental factors are explored by questionnaires including smoking,drinking,&#xD;
           pesticide and heavy metals.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2017</start_date>
  <completion_date type="Anticipated">February 1, 2027</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2027</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Database of Early-onset Parkinson's Disease</measure>
    <time_frame>10 years</time_frame>
    <description>To collect 3000 patients with early-onset parkinson's disease and establish the database of early-onset Parkinson's disease in mainland China.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Risk Factors</measure>
    <time_frame>10 years</time_frame>
    <description>To characterize clinical feature and environmental factors among Chinese early-onset parkinson's disease</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Genetic Basis</measure>
    <time_frame>10 years</time_frame>
    <description>To characterize the genetic basis of Chinese EOPD and detect clinically relevant genetic variants in these cases.</description>
  </primary_outcome>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>Parkinson Disease</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      extraction of DNA from peripheral blood&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        PD patients with early-onset&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients diagnosed with PD by UKBB and other standard criteria Age of onset is no more&#xD;
             than 50 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients have a family history of PD.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>J Guo, Ph.D.</last_name>
    <phone>+8613974936815</phone>
    <email>guojifeng2003@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Beisha Tang, Ph.D.</last_name>
    <phone>+8613974856709</phone>
    <email>bstang7398@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Xiangya Hospital of Central South University</name>
      <address>
        <city>Changsha</city>
        <state>Hunan</state>
        <zip>410000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jifeng Guo, Ph.D.</last_name>
      <phone>+8613974936815</phone>
      <email>guojifeng2003@163.com</email>
    </contact>
    <contact_backup>
      <last_name>Qiying Sun, Ph.D.</last_name>
      <phone>+8615874907260</phone>
      <email>sunqiying2015@163.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Yang Y, Tang BS, Weng L, Li N, Shen L, Wang J, Zuo CT, Yan XX, Xia K, Guo JF. Genetic Identification Is Critical for the Diagnosis of Parkinsonism: A Chinese Pedigree with Early Onset of Parkinsonism. PLoS One. 2015 Aug 21;10(8):e0136245. doi: 10.1371/journal.pone.0136245. eCollection 2015.</citation>
    <PMID>26295349</PMID>
  </reference>
  <reference>
    <citation>Liu ZH, Guo JF, Li K, Wang YQ, Kang JF, Wei Y, Sun QY, Xu Q, Wang DL, Xia K, Yan XX, Xu CS, Tang BS. Analysis of several loci from genome-wide association studies in Parkinson's disease in mainland China. Neurosci Lett. 2015 Feb 5;587:68-71. doi: 10.1016/j.neulet.2014.12.027. Epub 2014 Dec 17.</citation>
    <PMID>25528405</PMID>
  </reference>
  <reference>
    <citation>Li K, Tang BS, Liu ZH, Kang JF, Zhang Y, Shen L, Li N, Yan XX, Xia K, Guo JF. LRRK2 A419V variant is a risk factor for Parkinson's disease in Asian population. Neurobiol Aging. 2015 Oct;36(10):2908.e11-5. doi: 10.1016/j.neurobiolaging.2015.07.012. Epub 2015 Jul 11.</citation>
    <PMID>26234753</PMID>
  </reference>
  <results_reference>
    <citation>Liu Z, Tang B, Guo J, Zhou X, Sun Q, Xu Q, Xu C, Yan X. Mutations analysis of RAB39B gene in Chinese early-onset Parkinson's disease. Parkinsonism Relat Disord. 2016 Jul;28:157-8. doi: 10.1016/j.parkreldis.2016.03.019. Epub 2016 Mar 24.</citation>
    <PMID>27036214</PMID>
  </results_reference>
  <results_reference>
    <citation>Fan K, Tang BS, Wang YQ, Kang JF, Li K, Liu ZH, Sun QY, Xu Q, Yan XX, Guo JF. The GBA, DYRK1A and MS4A6A polymorphisms influence the age at onset of Chinese Parkinson patients. Neurosci Lett. 2016 May 16;621:133-136. doi: 10.1016/j.neulet.2016.04.014. Epub 2016 Apr 13.</citation>
    <PMID>27085534</PMID>
  </results_reference>
  <verification_date>April 2018</verification_date>
  <study_first_submitted>April 11, 2018</study_first_submitted>
  <study_first_submitted_qc>April 24, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">April 26, 2018</study_first_posted>
  <last_update_submitted>May 3, 2018</last_update_submitted>
  <last_update_submitted_qc>May 3, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">May 11, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Parkinson Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

